Programmes in BTI

CRISP Meats: CentRe of Innovation for Sustainable banking and Production of cultivated Meats

Around the world, urban cities are exploring ways to develop sustainable food solutions to boost their food resilience. Cultivated meat has been identified as a potential novel food production modality to enable urban cities to produce food at scale and grow their food systems. CRISP Meats is an integrated platform poised to tackle some of the major challenges that the industry encounters in cultivated meat production.

Hosted by BTI, in collaboration with other research entities and institutes-of-higher-learning, the programme has five workstreams to tackle the market needs in cell banking, culture media development, engineering & scaffold development. As a key player contributing to the development of cultivated meat products, CRISP Meats aims to help companies grow their businesses through R&D and create future food solutions for Singapore and beyond.  

Contact us at

CRISP Schematic 2024
Crisp Meats Collaboration Opportunities


The Pharma Innovation Programme Singapore (PIPS) is an industry-led platform which aims to synergistically and strategically bring together public sector research capabilities and domain expertise of the pharmaceutical industry to enhance the productivity and operational efficiency within Singapore’s pharmaceutical sector through leveraging novel manufacturing technologies and data analytics.

Through this concerted effort spanning the public sector, industry partners, academia and government agencies, we will resolve pertinent issues to value-add to the sector and beyond. The current workstreams within PIPS include Biocatalysis, Continuous Manufacturing, Digital Factory, Particle Engineering and Plant Operations.

The consortium will continue to evolve according to the needs of the industry and align ourselves to be a focal point of excellence.

Visit the PIPS website for more information

Contact us at

Biologics Pharma Innovation Programme Singapore (BioPIPS)

BioPIPS or the Biologics Pharma Innovation Programme Singapore aims to strengthen local biomanufacturing capabilities and transform Singapore’s biologics manufacturing facilities into agile factories of the future. It works through a consortium model consisting leading biopharma companies and Singapore’s public sector R&D agencies and universities. BioPIPS is modelled after PIPS.

Vision: Transform biologics manufacturing through the introduction of new technologies and products into Singapore’s manufacturing facilities. 

Find out more here.

Contact us at

BioPIPS intro

Connect with us